A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
- for people ages 1 month to 17 years
- at San Francisco, California and other locations
- study startedestimated completion:
Crohn's Disease Ulcerative Colitis Indeterminate Colitis Inflammatory Bowel Diseases Immunomodulators infliximab TNF-alpha
- accepting new patients
- Start Date
- Completion Date
- Janssen Biotech, Inc.
- To learn how to participate in this trial please click here.
- Study Type
- Last Updated
- June 1, 2017